Cue Biopharma Announces Pricing of $12.0 Million Public Offering
BOSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of […]
Theriva Biologics Announces Pricing of $2.5 Million Public Offering
ROCKVILLE, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) — Theriva Biologics, Inc. (NYSE American: TOVX) (“Theriva” or the “Company”), a diversified […]
Paramount Gold Nevada Provides Details of Its Upcoming AGM
WINNEMUCCA, Nev., Sept. 26, 2024 (GLOBE NEWSWIRE) — Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) is […]
Banzai Announces Closing of $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
SEATTLE, Sept. 26, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology […]
Provident Financial Holdings Announces Extension of September 2023 Stock Repurchase Plan
RIVERSIDE, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for […]
Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company […]
Uniti Group Inc. Announces Pricing of Windstream Refinancing Transactions
LITTLE ROCK, Ark., Sept. 26, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) today announced the pricing of […]
Doré Copper Announces Closing of $4.676 Million Non-Brokered Private Placement of Common Shares and Flow-Through Shares
Not for distribution to United States news wire services or for dissemination in the United States TORONTO, Sept. 26, 2024 […]
AvePoint Announces Expiration and Results of the Offer to Purchase and Consent Solicitation Relating to its Warrants
JERSEY CITY, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) — AvePoint (Nasdaq: AVPT, AVPTW), the global leader in robust data management […]
Cassava Sciences Resolves SEC Investigation
AUSTIN, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (“Cassava” or the “Company”) (Nasdaq: SAVA), a biotechnology company […]
